International Clinical Trial: Exploration of MRD-guided Venetoclax Bridging to Transition Continuous BTKi Therapy to Time-Limited Therapy in Chronic Lymphocytic Leukemia: A Prospective, Single-Arm, Phase 2 Study Protocol

Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122699) titled 'Exploration of MRD-guided Venetoclax Bridging to Transition Continuous BTKi Therapy to Time-Limited Therapy in Chronic Lymphocytic Leukemia: A Prospective, Single-Arm, Phase 2 Study Protocol' on April 16.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The West China Hospital of Sichuan University

Condition: Chronic Lymphocytic Leukemia

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-16

Target Sample Size: Experimental group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=313633

Publish...